COMMUNIQUÉS West-GlobeNewswire

Progyny Launches Two How-To Guides to Support Employers and their Employees as they Navigate Infertility in the Workplace

23/04/2018 - 15:00

NEW YORK, April 23, 2018 (GLOBE NEWSWIRE) -- In support of National Infertility Awareness Week (NIAW), Progyny, the leading fertility benefits management company, announced today the launch of two “How-To” guides geared [...]

Vous avez le feu vert pour sauver des vies : Semaine nationale de sensibilisation au don d’organes et de tissus (22-28 avril)

23/04/2018 - 15:00

À l’occasion de cette semaine de sensibilisation, nous souhaitons rappeler aux Canadiennes et aux Canadiens qu’ils doivent faire part à leurs proches de leur décision et de leurs volontés concernant le don d’organes. [...]

You have the green light to save a life: April 22-28 is National Organ and Tissue Donation Awareness Week

23/04/2018 - 15:00

This week we remind Canadians to talk with their friends, family and loved ones to ensure their organ donation wishes and decisions are understood. OTTAWA, April 23, 2018 (GLOBE NEWSWIRE) -- Green is the official colour [...]

Abba Medix Receives its License to Produce Cannabis Oil

23/04/2018 - 14:57

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, April 23, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) is pleased to [...]

Wildflower Completes Acquisition of Retail and Cultivation Licenses in LA

23/04/2018 - 14:50

VANCOUVER, British Columbia, April 23, 2018 (GLOBE NEWSWIRE) -- Wildflower Marijuana Inc. (CSE:SUN) (FWB:RSP) (“ Wildflower ” or the " Company ") has completed the acquisition of multiple California marijuana licenses [...]

AzurRx BioPharma and Mayoly-Spindler Announce Additional Positive Interim Data for MS1819-SD Phase II in Exocrine Pancreatic Insufficiency (EPI)

23/04/2018 - 14:45

BROOKLYN, N.Y., April 23, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma Inc. (NASDAQ: AZRX ) (“AzurRx” or the “Company”), today provided an update on the first nine treated patients in its ongoing Phase IIa trial of MS1819- [...]

Sarepta Therapeutics to Announce First Quarter 2018 Financial Results and Recent Corporate Developments on May 3, 2018

23/04/2018 - 14:30

CAMBRIDGE, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to [...]

Ultragenyx Announces Filing and FDA Clearance of an Investigational New Drug Application for DTX401, a Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia

23/04/2018 - 14:30

NOVATO, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today [...]

Vystar Acquires Assets of NHS Holdings

23/04/2018 - 14:30

Purchases Assets of NHS at a 70% Discount From $4.6 Million Valuation Transitions Vystar Focus from Rubber Commodities to Higher Revenue, Higher Margin Product Sales WORCESTER, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- [...]

Sarepta Therapeutics to Announce First Quarter 2018 Financial Results and Recent Corporate Devel-opments on May 3, 2018

23/04/2018 - 14:30

CAMBRIDGE, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to [...]

Acology Purchases Entire MedTainer Intellectual Property Portfolio

23/04/2018 - 14:30

Purchase Provides Catalysts to Rapid Global Expansion CORONA, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- Acology Inc. (OTC:ACOL) is pleased to announce the purchase of the entire intellectual property portfolio for [...]

Precision Therapeutics, Inc. Signs Letter of Intent to Purchase Remainder of Helomics Corporation Shares

23/04/2018 - 14:30

MINNEAPOLIS, April 23, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT ) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug [...]

Alder BioPharmaceuticals® Appoints Eric Carter, Ph.D., M.D., as Interim Chief Medical Officer

23/04/2018 - 14:30

BOTHELL, Wash., April 23, 2018 (GLOBE NEWSWIRE) -- Alder Biopharmaceuticals, Inc., (NASDAQ: ALDR ), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]

ARCA biopharma and Medtronic Extend Gencaro Clinical Trial Collaboration Agreement

23/04/2018 - 14:30

WESTMINSTER, Colo., April 23, 2018 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO ), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for [...]

HempAmericana Announces Augusta CBD Oil Facility Now “Open for Business”

23/04/2018 - 14:30

NEW YORK, April 23, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) is thrilled to announce that the new Vitalis R-200 high-capacity supercritical CO2 CBD Oil [...]

Intellia Therapeutics Announces In Vivo and Ex Vivo Data Presentations at the American Society of Gene and Cell Therapy 21st Annual Meeting

23/04/2018 - 14:30

CAMBRIDGE, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ: NTLA ), a leading genome editing company focused on the development of curative therapeutics using CRISPR/Cas9 technology, [...]

Accomplished International Medical Device Industry Executive, Ian Heynen, to Lead Profound Medical’s Sales and Marketing Function

23/04/2018 - 14:30

TORONTO, April 23, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V: PRN ) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]

Cambrex Completes New $3.2 Million Analytical Research & Development Laboratory at its High Point, NC Facility

23/04/2018 - 14:20

EAST RUTHERFORD, N.J., April 23, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM ), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that [...]

Abeona Announces FDA Grants RMAT Designation to ABO-102 Gene Therapy in MPS IIIA

23/04/2018 - 14:15

First Gene Therapy Using AAV Approach Granted Regenerative Medicine Advanced Therapy Designation NEW YORK and CLEVELAND, April 23, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ: ABEO ), a leading clinical- [...]